Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol versus oxytocin for bleeding control during cesarean section
ACTRN12610001018000Phase 4Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of misoprostol and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Ain Shams University. Primary endpoint: Intraoperative blood loss during elective lower segment cesarean sections. Planned start Dec 2010; status: not yet recruiting.
02
Drugs
misoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12610001018000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001018000.